VERRICO, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.295
EU - Europa 802
AS - Asia 321
AF - Africa 11
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.441
Nazione #
US - Stati Uniti d'America 1.281
IT - Italia 395
SE - Svezia 138
SG - Singapore 132
IN - India 93
CN - Cina 71
FI - Finlandia 48
DE - Germania 43
IE - Irlanda 33
FR - Francia 28
UA - Ucraina 25
GB - Regno Unito 21
BE - Belgio 19
ID - Indonesia 17
RO - Romania 13
BG - Bulgaria 11
CA - Canada 11
RU - Federazione Russa 8
TG - Togo 8
AR - Argentina 6
NL - Olanda 4
AL - Albania 3
BR - Brasile 3
ZA - Sudafrica 3
AT - Austria 2
CL - Cile 2
ES - Italia 2
LV - Lettonia 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
TW - Taiwan 2
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
TH - Thailandia 1
TM - Turkmenistan 1
Totale 2.441
Città #
Fairfield 152
Chandler 140
Ashburn 134
Rome 133
Singapore 101
Woodbridge 73
Houston 61
Seattle 54
Cambridge 53
Wilmington 52
Ann Arbor 41
Beijing 40
Princeton 40
Santa Clara 37
Dublin 31
San Paolo di Civitate 31
Plano 30
Lawrence 21
Boston 19
Milan 19
Millbury 19
Brussels 17
Jakarta 16
New York 16
Pune 15
Helsinki 14
San Diego 14
Boardman 12
Florence 12
Sofia 11
Norwalk 10
Bremen 9
Dallas 9
Andover 8
Jacksonville 8
Lomé 8
Cappelle sul Tavo 7
Southend 7
Dearborn 6
Federal 6
Frankfurt am Main 6
London 6
Paris 6
Toronto 6
Falkenstein 5
Fremont 5
Moscow 5
Ottawa 5
Villasanta 5
Des Moines 4
Genoa 4
Grafing 4
Naples 4
Turin 4
Washington 4
Albenga 3
Bologna 3
Castel d'Ario 3
Kunming 3
Lappeenranta 3
Mountain View 3
Mumbai 3
Munich 3
Padova 3
Palermo 3
Phoenix 3
Redwood City 3
Savona 3
Vicenza 3
Ancona 2
Bagheria 2
Bari 2
Bühl 2
Castellanza 2
Castelnuovo Magra 2
Falls Church 2
Fano 2
Faro 2
Ferrara 2
Giovinazzo 2
Grumo Nevano 2
Guangzhou 2
Hefei 2
Hyderabad 2
Imola 2
Jinan 2
Jinhua 2
Laurel 2
Livorno 2
Liège 2
Los Angeles 2
Lucca 2
Mexico City 2
Minori 2
Naro 2
Pomezia 2
Riga 2
Romainville 2
San Mateo 2
Seriate 2
Totale 1.663
Nome #
Angiogenic factors as prognostic markers in neuroendocrine neoplasms 172
Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation 119
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 118
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC) 118
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 85
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D) 83
Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment 70
Laser vaporization in the management of CIN 69
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis 69
Conservative approach to preneoplastic cervical lesions in postmenopause 61
Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100) 61
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family 59
Expression of er, pgr, her-2, and ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy 59
Nonpegylated liposomal doxorubicin (nPLD) in neoadjuvant treatment of local advanced breast cancer (LABC) patients (pts) 58
An unusual case of spleen metastasis from carcinoma ex pleomorphic adenoma of the parotid gland 55
Cell-free circulating tumor DNA(ctDNA) analysis by next generation sequencing(NGS) panel in non small cell lung cancer patients(NSCLC): implications in clinical practice. XX Congresso Nazionale AIOM 2018 (Poster D18) 54
BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT) 53
Neoplasie utero - Carcinoma della cervice uterina - Carcinoma dell’endometrio 52
Metachronous and synchronous cancers in patients with neuroendocrine tumors 50
Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review 50
EFFICACY AND SAFETY PROFILES OF PEGFILGRASTIM (P) AND LENOGRASTIM (L) IN NON METASTATIC BREAST CANCER (NMBC) PATIENTS RECEIVING ADJUVANT FEC100 49
null 48
NETest: a systematic review focusing on the prognostic and predictive role 48
Cervical intraepithelial neoplasia: Risk factors for persistence and recurrence in adolescents 47
Clinical management and follow-up of squamous intraepithelial cervical lesions during pregnancy and postpartum 46
null 45
Prognostic significance of laterality in lung neuroendocrine tumors 44
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma 42
Correlation between squamous intraepithelial lesions (SILs) and bacterial vaginosis 41
Correlation between bmi and chemotherapy related amenorrhea (cra) in premenopausal breast cancer patients (pbcp) 38
The strange case of a pancreatic neuroendocrine carcinoma with low proliferation index and atypical clinical behavior 38
Fertility and reproduction in breast cancer patients 37
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option? 37
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis 35
null 33
Correlation between BMI and chemotherapy related amenorrhea (CRA) in premenopausal breast cancer (PBC) patients treated with adjuvant anthracycline-cyclophosphamide (AC) and docetaxel (T) 32
L78 ROLE OF PEGFILGASTIM (P) AND LENOGASTIM (L) IN PATIENTS WITH NON-METASTATIC BREAST CANCER RECEIVING ADJUVANT FEC 100 CHEMOTHERAPY 32
Lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer patients (nmbcp) 31
Incidence of amenorrhea in premenopausal women with breast cancer (BC) undergoing chemotherapy (CT) with antracyclines (A), cyclophosfamide (C) and docetaxel (D) 31
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors 30
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials 29
null 29
INCIDENCE OF ANTRACYCLINE CARDIOTOXICITY IN BREAST CANCER WOMEN: A RETROSPECTIVE ANALYSIS OF 6 YEARS CLINICAL PRACTICE 27
Primary prophylaxis of neutropenia in women affected by breast cancer undergoing adjuvant chemotherapy with fec 100+/- docetaxel. Comparison of efficacy and tolerability between lenograstim and pegfilgrastim 25
Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art 24
L70 MANAGEMENT OF NEUTROPENIA: EFFICACY AND SAFETY OF LENOGASTIM (L) AND PEGFILGASTIM (P) IN NON-METASTATIC BREAST CANCER PATIENTS TREATED WITH FEC 100 PLUS DOCETAX 24
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? 23
Bevacizumab in ovarian cancer: A critical review of phase III studies 23
Incidence of chemotherapy (CT) induced amenorrhea in premenopausal patients (pts) with breast cancer (BC) following adjuvant anthracycline (A), cyclophosphamide (C), and taxane (T) 23
null 20
Efficacy, safety and cost-effectiveness (ce) analysis of lenograstim (l) versus pegfilgrastim (p) in management of chemotherapy related neutropenia (crn) in non metastatic breast cancer (bc) patients 19
The role of body mass index (bmi) on chemotherapy related amenorrhea (cra) in premenopausal breast cancer (bc) patients treated with adjuvant anthracycline , cyclophosphamide (ac) and taxane (t) 17
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms 10
New Prognostic Frontiers for Lung Neuroendocrine Tumors 8
Totale 2.600
Categoria #
all - tutte 9.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 0 0 30 45 36 53 37 27 18
2020/2021160 23 21 14 13 2 11 1 13 19 20 5 18
2021/2022438 1 11 29 31 54 15 12 51 48 25 86 75
2022/2023601 101 125 41 40 62 56 24 35 77 9 25 6
2023/2024456 22 45 25 39 52 111 15 37 9 33 34 34
2024/2025325 21 42 84 63 65 50 0 0 0 0 0 0
Totale 2.600